%0 Generic
%A Talbot, D.
%A Govindan, R.
%A Cobo, M.
%A Ponce Aix, S.
%A Postmus, P. E.
%A Lewanski, C.
%A Bennouna, J.
%A Fischer, J.
%A Juan-Vidal, O.
%A Stewart, D.
%A Ardizzoni, A.
%A Bhore, R.
%A Wolfsteiner, M.
%A Reck, M.
%A Morgensztern, D.
%A Ong, T. J.
%T Quality of Life in Patients with Advanced NSCLC Treated in Second-or Third-Line with Nab-Paclitaxel plus Durvalumab: ABOUND. 2L+
%D 2018
%@ 1556-0864
%U https://hdl.handle.net/10668/27925
%K quality of life
%K durvalumab
%K nab-paclitaxel
%~